245 related articles for article (PubMed ID: 32313951)
1. Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria.
Halloy F; Iyer PS; Ćwiek P; Ghidini A; Barman-Aksözen J; Wildner-Verhey van Wijk N; Theocharides APA; Minder EI; Schneider-Yin X; Schümperli D; Hall J
Nucleic Acids Res; 2020 May; 48(9):4658-4671. PubMed ID: 32313951
[TBL] [Abstract][Full Text] [Related]
2. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
[TBL] [Abstract][Full Text] [Related]
3. Abnormal mitoferrin-1 expression in patients with erythropoietic protoporphyria.
Wang Y; Langer NB; Shaw GC; Yang G; Li L; Kaplan J; Paw BH; Bloomer JR
Exp Hematol; 2011 Jul; 39(7):784-94. PubMed ID: 21627978
[TBL] [Abstract][Full Text] [Related]
4. Iron availability modulates aberrant splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase Jmjd6 and U2AF(65.).
Barman-Aksözen J; Béguin C; Dogar AM; Schneider-Yin X; Minder EI
Blood Cells Mol Dis; 2013 Oct; 51(3):151-61. PubMed ID: 23787363
[TBL] [Abstract][Full Text] [Related]
5. Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.
Mirmiran A; Schmitt C; Lefebvre T; Manceau H; Daher R; Oustric V; Poli A; Lacapère JJ; Moulouel B; Puy H; Karim Z; Peoc'h K; Lenglet H; Simonin S; Deybach JC; Nicolas G; Gouya L
Am J Hum Genet; 2019 Feb; 104(2):341-347. PubMed ID: 30712775
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.
Oustric V; Manceau H; Ducamp S; Soaid R; Karim Z; Schmitt C; Mirmiran A; Peoc'h K; Grandchamp B; Beaumont C; Lyoumi S; Moreau-Gaudry F; Guyonnet-Dupérat V; de Verneuil H; Marie J; Puy H; Deybach JC; Gouya L
Am J Hum Genet; 2014 Apr; 94(4):611-7. PubMed ID: 24680888
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietic protoporphyria.
Lecha M; Puy H; Deybach JC
Orphanet J Rare Dis; 2009 Sep; 4():19. PubMed ID: 19744342
[TBL] [Abstract][Full Text] [Related]
8. [Inheritance in erythropoietic protoporphyria].
Schmitt C; Ducamp S; Gouya L; Deybach JC; Puy H
Pathol Biol (Paris); 2010 Oct; 58(5):372-80. PubMed ID: 20850938
[TBL] [Abstract][Full Text] [Related]
9. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
Bloomer JR; Wang Y; Singhal A; Risheg H
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
[TBL] [Abstract][Full Text] [Related]
10. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
[TBL] [Abstract][Full Text] [Related]
11. The molecular genetics of erythropoietic protoporphyria.
Elder GH; Gouya L; Whatley SD; Puy H; Badminton MN; Deybach JC
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):118-26. PubMed ID: 19656460
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
[TBL] [Abstract][Full Text] [Related]
13. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria.
Di Pierro E; Cappellini MD; Mazzucchelli R; Moriondo V; Mologni D; Zanone Poma B; Riva A
Exp Hematol; 2005 May; 33(5):584-91. PubMed ID: 15850836
[TBL] [Abstract][Full Text] [Related]
14. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
[TBL] [Abstract][Full Text] [Related]
15. Liver disease and erythropoietic protoporphyria: a concise review.
Casanova-González MJ; Trapero-Marugán M; Jones EA; Moreno-Otero R
World J Gastroenterol; 2010 Sep; 16(36):4526-31. PubMed ID: 20857522
[TBL] [Abstract][Full Text] [Related]
16. Digital PCR (dPCR) analysis reveals that the homozygous c.315-48T>C variant in the FECH gene might cause erythropoietic protoporphyria (EPP).
Brancaleoni V; Granata F; Missineo P; Fustinoni S; Graziadei G; Di Pierro E
Mol Genet Metab; 2018 Aug; 124(4):287-296. PubMed ID: 29941360
[TBL] [Abstract][Full Text] [Related]
17. Identification of FECH gene multiple variations in two Chinese patients with erythropoietic protoporphyria and a review.
Long ZB; Wang YW; Yang C; Liu G; Du YL; Nie GJ; Chang YZ; Han B
J Zhejiang Univ Sci B; 2016 Oct.; 17(10):813-820. PubMed ID: 27704751
[TBL] [Abstract][Full Text] [Related]
18. Genetic study in a Singaporean patient with erythropoietic protoporphyria.
Chuah SY; Tee SI; Pramono ZA; Theng CT
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):269-71. PubMed ID: 22971195
[TBL] [Abstract][Full Text] [Related]
19. A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria.
Ma J; Xiao S; An J; Wang X; Xu Q; Dong Y; Feng Y; Wang J
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):726-9. PubMed ID: 19888946
[TBL] [Abstract][Full Text] [Related]
20. Liver metabolomics in a mouse model of erythropoietic protoporphyria.
Wang P; Sachar M; Guo GL; Shehu AI; Lu J; Zhong XB; Ma X
Biochem Pharmacol; 2018 Aug; 154():474-481. PubMed ID: 29906468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
